NHS England Adds Three New Therapies To Cancer Drugs Fund List

Roche’s Trastuzumab emtansine, Bayer’s Radium-223 dichloride, and GlaxoSmithKline’s Dabrafenib have been added to the National Health Service’s (NHS) Cancer Drugs Fund list. NHS England released the update this week.
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news